The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Open accessAbstract
BACKGROUND AND METHODS: Although cachexia often accompanies advanced heart failure, little is known about the causes of the cachectic state. To assess the potential role of tumor necrosis factor in the pathogenesis of cardiac cachexia, we measured serum levels of the factor in 33 patients with chronic heart failure, 33 age-matched healthy controls, and 9 patients with chronic renal failure. RESULTS: Mean (+/- SEM) serum levels of tumor necrosis factor were higher in the patients with heart failure (115 +/- 25 U per milliliter) than in the healthy controls (9 +/- 3 U per milliliter; P less than 0.001). Nineteen of the patients with chronic heart failure had serum levels of tumor necrosis factor greater than or equal to 39 U per milliliter (greater than 2 SD above the mean value for the control group), whereas the remaining 14 patients had serum levels of tumor necrosis factor below this level. The patients with high levels of tumor necrosis factor were more cachectic than those with low levels (82 +/- 3 vs. 95 +/- 6 percent of ideal body weight, respectively; P less than 0.05) and had more advanced heart failure, as evidenced by their higher values for plasma renin activity (2.92 +/- 0.53 vs. 1.06 +/- 0.53 ng per liter per second [10.5 +/- 1.9 vs. 3.8 +/- 1.9 ng per milliliter per hour]; P less than 0.01) and lower serum sodium concentration (135 +/- 1 vs. 138 +/- 1 mmol per liter; P less than 0.05). The group with high levels of tumor necrosis factor also had lower hemoglobin levels (7.82 +/- 0.2 vs. 8.69 +/- 0.4 mmol per liter [12.6 +/- 0.4 vs. 14.0 +/- 0.6 g per deciliter]) and higher values for blood urea nitrogen (19.5 +/- 2.2 vs. 12.5 +/- 1.8 mmol per liter) than the group with low levels of tumor necrosis factor (P less than 0.05 for both). The high levels of tumor necrosis factor were not due solely to decreased renal clearance, however, since the levels in the patients with heart failure were considerably higher than those in the nine patients with chronic renal failure (115 +/- 25 vs. 45 +/- 25 U per milliliter; P less than 0.05). CONCLUSIONS: These findings indicate that circulating levels of tumor necrosis factor are increased in cachectic patients with chronic heart failure and that this elevation is associated with the marked activation of the renin-angiotensin system seen in patients with end-stage cardiac disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in patients with congestive heart failure, the levels of pro-inflammatory cytokines, especially TNF, IL-6, and IL-1, are markedly elevated, and the TNF level is a negative prognostic factor”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity
Gillis, S. A., Ferm, M. M., Ou, W., & Smith, K. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.6.2027 · Cited by 3,273
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
Le, J., & Vilček, J. (1987) · PubMed · Cited by 1,327
Friedberg, C. K. (1966) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 1,308
Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 771
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E. P., Grau, G. E., Dayer, J., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., He, W., Manogue, K. R., Fong, Y., HESSE, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Lähdevirta, J., Maury, C. P. J., Teppo, A., & Repo, H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90576-1 · Cited by 717
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.
Kunkel, S. L., Spengler, M. L., May, M., Spengler, R. N., Larrick, J. W., & Remick, D. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60727-6 · Cited by 661
Tumors secreting human TNF/cachectin induce cachexia in mice
Oliff, A. I., Defeo-Jones, D., BOYER, M. E., Martinez, D., KIEFER, D. M., Vuocolo, G. A., Wolfe, A. L., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640
Saxne, T., Palladino, M. A., Heinegård, D. K., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 565
Lee, W. H., & Packer, M. (1986) · Circulation · doi:10.1161/01.cir.73.2.257 · Cited by 561
Self-citationNeurohormonal interactions and adaptations in congestive heart failure.
Packer, M. (1988) · Circulation · doi:10.1161/01.cir.77.4.721 · Cited by 537
Self-citationA Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
Torti, F. M., Dieckmann, B. S., Beutler, B., Cerami, A., & RINGOLD, G. M. (1985) · Science · doi:10.1126/science.3839597 · Cited by 519
RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS
Scuderi, P., Lam, K., Ryan, K., Petersen, E. A., STERLING, K. E., Finley, P. R., Ray, C. G., Slymen, D., & Salmon, S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92007-6 · Cited by 457
Prostaglandins in Severe Congestive Heart Failure
Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K., & Williams, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100603 · Cited by 428
Self-citationEVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER
Balkwill, F. R., Burke, F., Talbot, D., Tavernier, J. H., Osborne, R. H., Naylor, S., Durbin, H., & Fiers, W. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91850-2 · Cited by 417
Wilson, J. R., Schwartz, J. S., Sutton, M. S. J., Ferraro, N., Horowitz, L. N., Reichek, N., & Josephson, M. E. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80265-4 · Cited by 393
Renz, H., Gong, J., Schmidt, A. S., Nain, M., & Gemsa, D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2388 · Cited by 391
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Ruff, M. R., & Gifford, G. E. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1671 · Cited by 387
The renin system: Variations in man measured by radioimmunoassay or bioassay
Sealey, J. E., Gerten-Banes, J., & Laragh, J. H. (1972) · Kidney International · doi:10.1038/ki.1972.34 · Cited by 383
Bachwich, P. R., Chensue, S. W., Larrick, J. W., & Kunkel, S. L. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90881-8 · Cited by 337
Survival of patients with severe congestive heart failure treated with oral milrinone
Baim, D. S., Colucci, W. S., Monrad, E. S., Smith, H. S., Wright, R. F., Lanoue, A., Gauthier, D. F., Ransil, B. J., Grossman, W., & Braunwald, E. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80478-8 · Cited by 310
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., & Grünfeld, C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8313 · Cited by 277
Tumor necrosis factor induces glomerular damage in the rabbit.
Bertani, T., Abbate, M., Zoja, C., Corna, D., Perico, N., Ghezzi, P., & Remuzzi, G. (1989) · Europe PMC (PubMed Central) · Cited by 246
The Acute Metabolic Effects of Tumor Necrosis Factor Administration in Humans
Warren, R. S. (1987) · Archives of Surgery · doi:10.1001/archsurg.1987.01400240042007 · Cited by 233
Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease
Furukawa, S., Matsubara, T., Jujoh, K., Yone, K., Sugawara, T., Sasai, K., Kato, H., & Yabuta, K. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90088-8 · Cited by 213
Davis, G. C., Kissinger, P. T., & Shoup, R. E. (1981) · Analytical Chemistry · doi:10.1021/ac00225a006 · Cited by 209
Tumour necrosis factor in man: Clinical and biological observations
Selby, P. J., Hobbs, S., Viner, C., Jackson, E. B., Jones, A. L., Newell, D. R., Calvert, H., McElwain, T. J., Fearon, K. C. H., & HUMPHREYS, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.294 · Cited by 203
Carr, J., Stevenson, L., Walden, J., & Heber, D. (1989) · American Journal of Cardiology · doi:10.1016/0002-9149(89)90256-7 · Cited by 203
The Pathogenesis of Cardiac Cachexia
Pittman, J. G., & Cohen, P. (1964) · New England Journal of Medicine · doi:10.1056/nejm196408202710807 · Cited by 201
Assays for tumour necrosis factor and related cytokines
Meager, A., Leung, H., & Woolley, J. A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90306-2 · Cited by 196
Packer, M., Medina, N., & Yushak, M. (1985) · Circulation · doi:10.1161/01.cir.71.4.761 · Cited by 182
Self-citationCachectin: A Hormone that Triggers Acute Shock and Chronic Cachexia
Tracey, K. J., Lowry, S. F., & Cerami, A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.3.413 · Cited by 178
DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES
Katz, A. M., & Katz, P. B. (1962) · Heart · doi:10.1136/hrt.24.3.257 · Cited by 169
Tumor necrosis factor in the serum of patients with systemic lupus erythematosus
Maury, C. P. J., & Teppo, A. M. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320206 · Cited by 149
Peetre, C., Gullberg, U., Nilsson, E., & Olsson, I. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112764 · Cited by 148
SCHOOLEY, J. C., Kullgren, B., & ALLISON, A. C. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb02289.x · Cited by 144
Malnutrition in Cardiac Surgical Patients
Abel, R. M. (1976) · Archives of Surgery · doi:10.1001/archsurg.1976.01360190047008 · Cited by 141
Pekala, P. H., Kawakami, M., Angus, C., Lane, M. D., & Cerami, A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2743 · Cited by 141
Cellular Immunity in Adult Marasmus
Bistrian, B. R. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.10.1408 · Cited by 121
Role of Biochemical Mediators in Clinical Nutrition and Surgical Metabolism
Pomposelli, J. J., Flores, E. A., & Bistrian, B. R. (1988) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607188012002212 · Cited by 118
The role of tumor necrosis factor (cachectin) in cachexia
Oliff, A. (1988) · Cell · doi:10.1016/0092-8674(88)90543-0 · Cited by 115
Lilly, L. S., Dzau, V. J., Williams, G. H., Rydstedt, L. L., & Hollenberg, N. K. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-924 · Cited by 101
Lectin-gold labeling of glycoconjugates in normal and Brattleboro rat papilla: effect of vasopressin
Weyer, P., Brown, D. J., & Orci, L. (1988) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1988.254.3.c450 · Cited by 64
Malabsorption as a complication of congestive heart failure
Berkowitz, D., Groll, M. N., & LIKOFF, W. B. (1963) · The American Journal of Cardiology · doi:10.1016/0002-9149(63)90029-8 · Cited by 57
Tumor Necrosis Factor in Leprosy Patients
Silva, C. A., & Foss, N. T. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.4.787 · Cited by 53
Is Circulating Tumor Necrosis Factor Bioactive?
Duncombe, A. S., & Brenner, M. K. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191817 · Cited by 40
Continuous infusion of tumor necrosis factor: Mechanisms of toxicity in the rat
Gaskill, H. V. (1988) · Journal of Surgical Research · doi:10.1016/0022-4804(88)90098-4 · Cited by 37
Potassium Depletion in Severe Heart Disease
White, R. J., Chamberlain, D. A., Hamer, J., McAlister, J. M., & Hawkins, L. A. (1969) · BMJ · doi:10.1136/bmj.2.5657.606 · Cited by 32
PESSINA, G. P., Pacini, A., Bocci, V. A., Maioli, E., & Naldini, A. (1987) · PubMed · Cited by 30
STUDIES ON THE MECHANISM OF THE INCREASED OXYGEN CONSUMPTION IN PATIENTS WITH CARDIAC DISEASE
Resnik, H., & Friedman, B. (1935) · Journal of Clinical Investigation · doi:10.1172/jci100705 · Cited by 28
Total body and serum electrolyte composition in heart failure: the effects of captopril
Cleland, J. G. F., Dargie, H. J., East, B. W., ROBERTSON, I., Hodsman, G. P., BALL, S. G., GlLLEN, G., Robertson, J. I. S., & Morton, J. J. (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061920 · Cited by 27
Research works printed but not linked: 4
- Packer, 1987, Circulation, 75, IV-80
- Bertani, 1989, Am J Pathol, 134, 419
- Pessina, 1987, Lymphokine Res, 6, 35
- Le, 1987, Lab Invest, 56, 234
Cited by
Sorted by citations
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Self-citationWasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P. P., Varney, S. J., Chua, T. P., Clark, A. L., Webb-Peploe, K., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Multiple Organ Failure Pathophysiology and Potential Future Therapy
Deitch, E. A. (1992) · Annals of Surgery · doi:10.1097/00000658-199208000-00002 · Cited by 1,378
Metadata
- Authors
- Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M.
- Affiliations
- City University of New York (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-07-26
- Volume
- 323
- Issue
- 4
- Pages
- 236-241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2324476825
- Cited by
- 2,582
- References
- 55
- Citations by year
- 2026: 21 · 2025: 43 · 2024: 49 · 2023: 34 · 2022: 70 · 2021: 63 · 2020: 64 · 2019: 64 · 2018: 59 · 2017: 64 · 2016: 58 · 2015: 70 · 2014: 75 · 2013: 73 · 2012: 79
- FWCI
- 29.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r01hl025055-11, 5r01ca041583-06, 5k04hl001229-02)
- National Heart, Lung, and Blood Institute (KO4-HL-01229, R01-HL-25055)
- National Cancer Institute (R01-CA41583)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- TNF-α, chronic heart failure, cardiac cachexia, serum cytokines, plasma renin activity, serum sodium, hemoglobin, blood urea nitrogen, chronic kidney disease, cytokine clearance, advanced heart failure, weight loss, inflammation in heart failure, anemia of heart failure, hyperuricemia, hyperkalemia
- MeSH terms
- Adult, Aged, Aged, 80 and over, Chronic Disease, Female, Heart Failure, Hemoglobins, Humans, Male, Middle Aged, Renin, Sodium, Tumor Necrosis Factor-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
